Venus Remedies Ltd has launched anti-biotic, Mucomelt-Forte. The company is planning to launch new products in near future for domestic market.
The Biocard division of the company has launched the FDC of Cefixime with N Acetylcysteine, for the first time in India. This unique combination has been launched in the anti-biotic segment for the treatment of respiratory tract infections and COPD. This new formulation shall be a boon for the bronchitis patients, especially because the acetylcysteine counters the high oxidative stress in the respiratory tract.
It further fortifies the efficacy of Cefixime antibiotic by inhibiting the adherence of S Pneumonia and H Influenza, thus enhancing the antibiotic penetration. The formulation is proved to be a superior cure as compared to treatment with other antibiotics like Cefaclor and Cefuroxime.
This new launch has added another brand in the range of the company's product basket for the respiratory segment.